Paper41767945
CRISPR-based genome editing reveals the roles of efflux pumps in Mycobacterium abscessus.
Li S and 7 others. mLife, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. CRISPR-based genome editing reveals the roles of efflux pumps in Mycobacterium abscessus. Papers, record 41767945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41767945
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CRISPR-based genome editing reveals the roles of efflux pumps in Mycobacterium abscessus.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27899676 | TransportDB 2.0: a database for exploring membrane transporters in sequenced genomes from all domains of life. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/27899676 | PubMed |
| 2 | 8284673 | inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. | Science | 1994 | https://conductscience.org/library/papers/8284673 | PubMed |
| 3 | 35659317 | Transposon mutagenesis in Mycobacterium abscessus identifies an essential penicillin-binding protein involved in septal peptidoglycan synthesis and antibiotic sensitivity. | Elife | 2022 | https://conductscience.org/library/papers/35659317 | PubMed |
| 4 | 34957465 | Programmable Base Editing in Mycobacterium tuberculosis Using an Engineered CRISPR RNA-Guided Cytidine Deaminase. | Front Genome Ed | 2021 | https://conductscience.org/library/papers/34957465 | PubMed |
| 5 | 31992616 | A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis. | mBio | 2020 | https://conductscience.org/library/papers/31992616 | PubMed |
| 6 | 31209005 | Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31209005 | PubMed |
| 7 | 28165460 | Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. | Nat Microbiol | 2017 | https://conductscience.org/library/papers/28165460 | PubMed |
| 8 | 16438679 | Role of mycobacterial efflux transporters in drug resistance: an unresolved question. | FEMS Microbiol Rev | 2006 | https://conductscience.org/library/papers/16438679 | PubMed |
| 9 | 32829077 | Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9. | Tuberculosis (Edinb) | 2020 | https://conductscience.org/library/papers/32829077 | PubMed |
| 10 | 20812214 | Genetic manipulation of Mycobacterium abscessus. | Curr Protoc Microbiol | 2010 | https://conductscience.org/library/papers/20812214 | PubMed |
| 11 | 32761242 | Direct visualisation of drug-efflux in live Escherichia coli cells. | FEMS Microbiol Rev | 2020 | https://conductscience.org/library/papers/32761242 | PubMed |
| 12 | 12368434 | Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. | Microbiology (Reading) | 2002 | https://conductscience.org/library/papers/12368434 | PubMed |
| 13 | 28646112 | CRISPR-Cas12a-Assisted Recombineering in Bacteria. | Appl Environ Microbiol | 2017 | https://conductscience.org/library/papers/28646112 | PubMed |
| 14 | 34946129 | Mycobacterium abscessus Genetic Determinants Associated with the Intrinsic Resistance to Antibiotics. | Microorganisms | 2021 | https://conductscience.org/library/papers/34946129 | PubMed |
| 15 | 32870060 | Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease. | Ann Am Thorac Soc | 2020 | https://conductscience.org/library/papers/32870060 | PubMed |
| 16 | 10685681 | Transformation and transposition of the genome of Mycobacterium marinum. | Am J Vet Res | 2000 | https://conductscience.org/library/papers/10685681 | PubMed |
| 17 | 34126767 | Genome-Wide Essentiality Analysis of Mycobacterium abscessus by Saturated Transposon Mutagenesis and Deep Sequencing. | mBio | 2021 | https://conductscience.org/library/papers/34126767 | PubMed |
| 18 | 22290346 | Mycobacterium abscessus: a new antibiotic nightmare. | J Antimicrob Chemother | 2012 | https://conductscience.org/library/papers/22290346 | PubMed |
| 19 | 32104016 | Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/32104016 | PubMed |
| 20 | 38319218 | A dual-plasmid CRISPR/Cas9-based method for rapid and efficient genetic disruption in Mycobacterium abscessus. | J Bacteriol | 2024 | https://conductscience.org/library/papers/38319218 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41767945
GET https://conductscience.org/api/papers/v1/41767945/references?page=2